Treat-to-target concept implementation for evaluating rheumatoid arthritis patients in daily practice

被引:10
|
作者
Gazitt, Tal [1 ]
Oren, Shirley [2 ]
Reitblat, Tatiana [3 ]
Lidar, Merav [4 ]
Gurman, Alexandra Balbir [5 ]
Rosner, Itzhak [6 ]
Halabe, Nimer [7 ]
Feld, Joy [1 ]
Kassem, Sameer [7 ]
Lavi, Idit [8 ]
Elkayam, Ori [9 ]
Zisman, Devy [1 ]
机构
[1] Carmel Hosp, Dept Rheumatoi, Haifa, Israel
[2] Rabin Med Ctr, Dept Rheumatol, Petah Tiqwa, Israel
[3] Barzilai Govt Hosp, Dept Rheumatol, Ashqelon, Israel
[4] Chaim Sheba Med Ctr, Zabludowicz Ctr Autoimmune Dis, Rheumatol Unit, Tel Aviv, Israel
[5] Rambam Hlth Care Campus, B Shine Rheumatol, Haifa, Israel
[6] Bnai Zion Med Ctr, Dept Rheumatol, Haifa, Israel
[7] Carmel Hosp, Dept Internal Med, Haifa, Israel
[8] Carmel Hosp, Dept Community Med & Epidemiol, Haifa, Israel
[9] Tel Aviv Sourasky Med Ctr, Dept Rheumatol, Tel Aviv, Israel
关键词
Treat to target (T2T); rheumatoid arthritis (RA); disease activity measures; DISEASE-ACTIVITY; OPPORTUNITY; STRATEGIES; MANAGEMENT; MORTALITY; PROTEIN; WINDOW;
D O I
10.5152/eurjrheum.2019.18195
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We aimed to assess the implementation of the treat-to-target (T2T) concept in rheumatoid arthritis (RA) patients in daily practice. Methods: All RA patients visiting one of the 7 academic medical centers in Israel in June 2015 with at least 3 previous clinic visits were included in this study. A common questionnaire was used to collect data from patients' medical records, and two independent rheumatologists evaluated the collected data for the implementation of the T2T concept. The associations between T2T implementation and the categorical and continuous variables were assessed. Results: The study included 724 patients with a mean (standard deviation) age of 62.6 (13.97) years and 575 (80.4%) of them were women. Four centers used more than one scoring method, with Disease Activity Score-28 and Clinical Disease Activity Index) being most commonly used. Only 276 (38.1%) patients had disease score results in >= 3 visits, and the T2T recommendations were implemented for 245 (33.8%) of the 724 patients. The rate of implementation was higher in younger (p=0.028) rheumatoid factor-positive patients (p=0.011) and varied between centers (11.1%-87% p< 0.0001). T2T implementation did not correlate to gender, place of residence, education, tobacco use, treatment regimens, and presence of erosions or comorbidities. Conclusion: The T2T concept was implemented on only 33.8% of patients and was not affected by RA disease severity. Further studies are needed to determine the reasons for this deviation from the T2T standard of care for RA as well as its consequences.
引用
收藏
页码:136 / 141
页数:6
相关论文
共 50 条
  • [31] Adherence to a Treat-to-Target (T2T) Strategy in Early Rheumatoid Arthritis. Is It Feasible in Daily Clinical Practice?
    Waimann, Christian A.
    Citera, Gustavo
    Dal Pra, Fernando
    Celeste Orozco, Maria
    Ceccatto, Federico
    Paira, Sergio
    Gauna, M.
    Secco, Anastasia
    Mamani, M.
    Marino, Lucila
    Caeiro, Francisco
    Alvarez, A. C.
    Haye Salinas, Maria
    Encinas, L.
    Rosa, Javier
    Scaglioni, Valeria
    Soriano, Enrique R.
    Marcos, Josefina
    Garcia, Mercedes
    Salas, A.
    Martinez, Alejandro
    Chaparro del Moral, Rafael
    Luis Rillo, Oscar
    Berman, Horacio
    Berman, Alberto
    Colombres, Francisco
    Veloso, Edson
    Juarez, Ricardo V.
    Elena Crespo, Maria
    Quinteros, Ana
    Leal, M.
    Salvatierra, Gabriela
    Ledesma, C.
    Sacnun, Monica P.
    Quintana, R.
    Abdala, Marcelo
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1037 - S1037
  • [32] IMPROVING TREAT-TO-TARGET IMPLEMENTATION IN RHEUMATOID ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW OF BARRIERS, FACILITATORS, AND INTERVENTIONS
    Gossec, L.
    Bessette, L.
    Xavier, R.
    Favalli, E. G.
    Ostor, A.
    Buch, M. H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 572 - 572
  • [33] Treat-to-Target Approach in Rheumatoid Arthritis: A Quality Improvement Trial
    Desai, Sonali P.
    Leatherwood, Cianna
    Forman, Malka
    Ko, Eunji
    Stevens, Emma
    Iversen, Maura
    Xu, Chang
    Lu, Bing
    Solomon, Daniel H.
    [J]. ARTHRITIS CARE & RESEARCH, 2021, 73 (02) : 207 - 214
  • [34] GLUCOCORTICOIDS IN THE INITIAL TREAT-TO-TARGET STRATEGY OF EARLY RHEUMATOID ARTHRITIS
    Fedele, A. L.
    Petricca, L.
    Tolusso, B.
    Alivernini, S.
    Gigante, M. R.
    Bosello, S. L.
    Di Mario, C.
    Ferraccioli, G.
    Gremese, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1286 - 1287
  • [35] Implementation of treat-to-target in rheumatoid arthritis through a Learning Collaborative: Rationale and design of the TRACTION trial
    Solomon, Daniel H.
    Lee, Sara B.
    Zak, Agnes
    Corrigan, Cassandra
    Agosti, Jenifer
    Bitton, Asaf
    Harrold, Leslie
    Losina, Elena
    Lu, Bing
    Pincus, Ted
    Radner, Helga
    Smolen, Josef
    Katz, Jeffrey N.
    Fraenkel, Liana
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2016, 46 (01) : 81 - 87
  • [36] IMPLEMENTATION OF THE TREAT TO TARGET CONCEPT IN EVALUATION OF PSORIATIC ARTHRITIS PATIENTS
    Abu Elhija, M.
    Haddad, A.
    Lavi, I.
    Gazitt, T.
    Zisman, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 362 - 363
  • [37] TREAT-TO-TARGET IN AXIAL SPONDYLOARTHRITIS: AN OBSERVATIONAL STUDY IN DAILY PRACTICE
    Beckers, E.
    Boonen, A.
    Webers, C.
    Klooster, P. M.
    Vonkeman, H. E.
    Efde, M.
    van Tubergen, A.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1233 - 1234
  • [38] Implementation of Treat-to-Target in Rheumatoid Arthritis Through a Learning Collaborative Results of a Randomized Controlled Trial
    Solomon, Daniel H.
    Losina, Elena
    Lu, Bing
    Zak, Agnes
    Corrigan, Cassandra
    Lee, Sara B.
    Agosti, Jenifer
    Bitton, Asaf
    Harrold, Leslie R.
    Pincus, Theodore
    Radner, Helga
    Yu, Zhi
    Smolen, Josef S.
    Fraenkel, Liana
    Katz, Jeffrey N.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69 (07) : 1374 - 1380
  • [39] Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practice
    Versteeg, G. A.
    Steunebrink, L. M. M.
    Vonkeman, H. E.
    ten Klooster, P. M.
    van der Bijl, A. E.
    van de laar, M. A. F. J.
    [J]. CLINICAL RHEUMATOLOGY, 2018, 37 (05) : 1189 - 1197
  • [40] Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practice
    G. A. Versteeg
    L. M. M. Steunebrink
    H. E. Vonkeman
    P. M. ten Klooster
    A. E. van der Bijl
    M. A. F. J. van de Laar
    [J]. Clinical Rheumatology, 2018, 37 : 1189 - 1197